Stem CentRx

Stemcentrx researches, discovers, develops and commercializes therapies that cure and improve survival for cancer patients. Read more

Brian Slingerland's photo - Co-Founder & CEO of Stem CentRx

Co-Founder & CEO

Brian Slingerland

CEO Approval Rating

69/100

Founded:

2008

Status:

PrivateSubsidiary of Abbvie Inc.

STEM CENTRX TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Aileron Therapeutics is perceived as one of Stem CentRx's biggest rivals. Aileron Therapeutics's headquarters is in Watertown, Massachusetts, and was founded in 2005. Aileron Therapeutics operates in the Health Care Services industry. Aileron Therapeutics generates 14% of Stem CentRx's revenue.

ARIAD has been one of Stem CentRx's top competitors. ARIAD is a Private company that was founded in 1991 in Cambridge, Massachusetts. ARIAD operates in the Pharmaceuticals industry. Compared to Stem CentRx, ARIAD has 403 more employees.

Jounce is Stem CentRx's #3 rival. Jounce was founded in Cambridge, Massachusetts} in 2012. Jounce is in the Pharmaceuticals industry. Compared to Stem CentRx, Jounce generates $122.4M more revenue.

Weigh-in!

Help the Owler community know more

Growth Score - 1/1

Is 56 a good estimate for Stem CentRx's Employee count?

Stem CentRx Acquisitions

No recent acquisitions found related to Stem CentRx

Stem CentRx Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Equity
Jun 2014
--

Sequoia Capital

Since Stem CentRx was founded in 2008, it has participated in 1 round of funding. In total Stem CentRx has raised $0. Stem CentRx's funding round was on Jun 2014 for a total of $0

Stem CentRx Investments

No recent investments found related to Stem CentRx

Stem CentRx News

January 25, 2019The Wall Street Journal - Digits

Drug Maker AbbVie Swings to Loss on Charge from Stemcentrx Deal

Competition from lower-cost copies of Abbvie's top-selling drug and a $4.1 charge billion related to ... See more »
January 5, 20194-traders

to Record $4 Billion Impairment on Stemcentrx Assets - Update

(marketscreener.com) By Maria Armental AbbVie Inc. will book a roughly $4 billion charge in connectio... See more »
April 30, 2018FierceBiotech

AbbVie halts trial of Stemcentrx-sourced ADC for cancer

AbbVie has terminated an early-stage trial of an antibody drug conjugate (ADC) for solid tumors, one ... See more »
March 22, 2018MarketWatch

AbbVie stock tumbles 11% on disappointing results for cancer drug acquired in $5.8 billion deal

Investors were hoping for accelerated approval so the drug could quickly begin bringing in revenue. B... See more »
March 22, 2018Xconomy

AbbVie Shares Plummet as $5.8B Bet on Stemcentrx Takes a Hit

There is still a chance that AbbVie's $5.8 billion gamble on acquiring Stemcentrx, a privately held d... See more »
September 9, 2016FierceBiotech

IDbyDNA taps YouTube, Stemcentrx backer to develop infectious disease data platform

IDbyDNA taps YouTube, Stemcentrx backer to develop infectious disease data platform ntaylor Fri, 09/0... See more »
June 5, 2016Business Insider

Here's the cancer data that led AbbVie to make the second-largest acquisition in the history of venture capital

Flickr/Christina Tu, Sue & Bill Gross Stem Cell Research CenterUntil now, the second-largest acquisit... See more »

Social Media

Stem CentRx Headquarters

450 E Jamie Ct 3rd Floor

South San Francisco, California94080

650-491-0120

Driving Directions »

Trending Companies

Stem CentRx Summary

ABOUT

Overview

Stemcentrx researches, discovers, develops and commercializes therapies that cure and improve survival for cancer patients. Stem CentRx was founded in 2008. Stem CentRx's headquarters is located in South San Francisco, California, USA 94080. It has ra...

CEO

Stem CentRx's Co-Founder & CEO, Brian Slingerland, currently has an approval rating of 69%. Stem CentRx's primary competitors are Aileron Therapeutics, ARIAD & Jounce.

Frequently Asked Questions about Stem CentRx

  1. When was Stem CentRx founded?

    Stem CentRx was founded in 2008
  2. Who is Stem CentRx's CEO?

    Stem CentRx's CEO is Brian Slingerland
  3. How much revenue does Stem CentRx generate?

    Stem CentRx generates $27M in revenue
  4. How much funding does Stem CentRx have?

    Stem CentRx has historically raised $0 in funding
  1. Where is Stem CentRx's headquarters?

    Stem CentRx's headquarters is in South San Francisco California, USA
  2. How many employees does Stem CentRx have?

    Stem CentRx has 56 employees
  3. What sector does Stem CentRx operate in?

    Stem CentRx is in Biotechnology
  4. Who are Stem CentRx's competitors?

    Stem CentRx's top competitors are Aileron Therapeutics, ARIAD, Jounce